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The work described i n t h i s paper was sponsored by t h e Atomic Energy Cosmrieaion. Feldes a, i n 1940, s t a t e d that modified essential metabolites should be s u f f i c i e n t l y closely r e l a t e d to the e s s e n t i a l metabolites on which they a r e based as t o f i t the same enzyme, but s u f f i c i e n t l y d i f f e r e n t t o be devoid of essential metabolic activity, Since various investf gators had reported that the concentration of nucleic acids i n tumor-bearing animals i s greater than i n normal, animals, i t was apparent t h a t adenine and guanine i n h i b i t o r s might be found which would retard tumor growth, without adversely affecting the whole animal,
Hitchings a and Burchenal have demonstrated the adenine Inhibition of 2,6-diaminopurine, and Hitchings a and Kidder showed the antimetabolite action of 8-azaguanine, I n t h i s laboratory we have been working on the synthesis of some thiasolinopurines related t o 2,6-diaminopurine4 and t o other purines t o be reported l a t e r , None of the compounds prepared i n this program t o date
The work described i n t h i s paper was sponsored by the Atomic Energy Gomission, The syntheses of these compounds a r e being reported elsewhere.
showed any cancer-inhibiting action, but they are being reported in an effort to avoid duplication by other investigators. Some of the pyrimidines reported were used as intermediates in other syntheses, but are included here since their anti-leukemic possibilities had not previously been explored,
The customary screening procedure was carried out using C57 black mice into which had been implanted either the undifferentiated adenocarcinoma IPio 771 or the myeloid leukemia C W 8 . Dosage of the compounds to be screened was arbitrarily set at 4% of the PBZD/~O dose, except in cases where the animals reacted unfavorably to this amount, 
